SRSF6, AGO4, BRWD3, KDM6B, PHF21A and BRWD1 epigenetic regulators were selected from those 200 genes that showed the greatest difference in the case of comparing crizotinib-treated and -untreated ALCL cells. This evidence concerns the gene PHF21A and anaplastic large cell lymphoma.